Skip to search formSkip to main contentSkip to account menu

Pravastatin

Known as: Pravastatine, [1S-[1alpha(betaS*,deltaS*),2alpha,6alpha,8beta(R*),8aalpha]]-1,2,6,7,8,8a-Hexahydro-beta,!d,6-trihydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1-naphthaleneheptanoic Acid, Pravastatin [Chemical/Ingredient] 
A synthetic lipid-lowering agent. Pravastatin competitively inhibits hepatic hydroxymethyl-glutaryl coenzyme A (HMG-CoA) reductase, the enzyme which… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
The aim of the study was to evaluate effect of pravastatin therapy on erythrocyte aggregation in patients with arterial… 
2007
2007
AbstractReactive cardiomyocyte hypertrophy after myocardial infarction is an important risk factor for arrhythmias. Myocardial… 
1999
1999
Patients with non-insulin dependent (type 2) diabetes have a 2–5-fold increase in age adjusted mortality from coronary heart… 
1998
1998
textabstractDe consensustekst betreffende een verhoogde cholesterolconcentratie is voor de tweede maal herzien. In angiografische… 
Review
1998
Review
1998
Although drug eruptions caused by pravastatin and other lovastatin analogs have previously been described, reports of lichenoid… 
1998
1998
A 46-yr-old airline captain with many exposures to altitude chamber, fighter, and airliner flight developed migraine-type… 
1997
1997
BACKGROUND The pathogenesis of transplant coronary artery disease (TxCAD) is probably multifactorial. Immune mechanisms may be… 
Highly Cited
1996
Highly Cited
1996
HMG-CoA reductase inhibitors (statins), cholesterol-lowering drugs that have not been approved for use in children and… 
1993
1993
The safety, tolerability, and efficacy of 20 mg daily doses of simvastatin and pravastatin were compared in this double-blind…